Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro toxin a production

Gut Microbes

Volumn 3, Issue 6, 2012, Pages 523-529

  Kolling, Glynis L ^a   Wu, Martin ^a   Warren, Cirle A ^a   Durmaz, Evelyn ^b   Klaenhammer, Todd R ^b   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Clostridium difficile; Mouse model; Probiotic; Streptococcus thermophilus

Indexed keywords

LACTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CECUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STREPTOCOCCUS THERMOPHILUS; ULTRAVIOLET IRRADIATION; WEIGHT REDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIAL TOXINS; BODY WEIGHT; CECUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DISEASE MODELS, ANIMAL; ENTEROTOXINS; HUMANS; LACTIC ACID; MICE; MICROBIAL VIABILITY; STREPTOCOCCUS THERMOPHILUS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; MURINAE; MUS; STREPTOCOCCUS THERMOPHILUS;

EID: 84868549640     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.21757     Document Type: Article

References (23)

1. Baxter R, Ray GT, Fireman BH. Case-control study of antibiotic use and subsequent Clostridium difficile- associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:44-50; PMID:18171186; http://dx.doi.org/10.1086/524320.
2. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136:1913-24; PMID:19457419; http://dx.doi.org/10.1053/j.gastro.2009.02.073.
3. Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP. The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol 2010; 300:387-95; PMID:20547099; http://dx.doi.org/10.1016/j.ijmm.2010.04.008.
4. Pawlowski SW, Archbald-Pannone L, Carman RJ, Alcantara-Warren C, Lyerly D, Genheimer CW, et al. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone- resistant C. difficile. J Hosp Infect 2009; 73:185-7; PMID:19709778; http://dx.doi.org/10.1016/j.jhin.2009.05.013.
5. McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 2009; 15:274-80; PMID:19825425; http://dx.doi.org/10.1016/j.anaerobe.2009.09.002.
6. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636-41; PMID:20145608; http://dx.doi.org/10.1038/ajg.2010.11.
7. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335:80; PMID:17604300; http://dx.doi.org/10.1136/bmj.39231.599815.55.
8. Petrof EO. Probiotics and gastrointestinal disease: Clinical evidence and basic science. Antiinflamm Antiallergy Agents Med Chem 2009; 8:260-9; PMID:20890386.
9. Fontaine L, Hols P. The inhibitory spectrum of thermophilin 9 from Streptococcus thermophilus LMD-9 depends on the production of multiple peptides and the activity of BlpG(St), a thiol-disulfide oxidase. Appl Environ Microbiol 2008; 74:1102-10; PMID:18156339; http://dx.doi.org/10.1128/AEM.02030-07.
10. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31:1012-7; PMID:11049785; http://dx.doi.org/10.1086/318130.
11. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-8; PMID:8201735; http://dx.doi.org/10.1001/jama.1994.03510480037031.
12. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008; 135:1984-92; PMID:18848941; http://dx.doi.org/10.1053/j.gastro.2008.09.002.
13. Rul F, Ben-Yahia L, Chegdani F, Wrzosek L, Thomas S, Noordine ML, et al. Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats. J Biol Chem 2011; 286:10288-96; PMID:21239485; http://dx.doi.org/10.1074/jbc.M110.168666.
14. Corthier G, Dubos F, Raibaud P. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol 1985; 49:250-2; PMID:3977313.
15. Banerjee P, Merkel GJ, Bhunia AK. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 2009; 1:8; PMID:19397787; http://dx.doi.org/10.1186/1757-4749-1-8.
16. Naaber P, Smidt I, Stsepetova J, Brilene T, Annuk H, Mikelsaar M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J Med Microbiol 2004; 53:551-4; PMID:15150337; http://dx.doi.org/10.1099/jmm.0.45595-0.
17. Trejo FM, Minnaard J, Perez PF, De Antoni GL. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006; 12:186-93; PMID:16759886; http://dx.doi.org/10.1016/j.anaerobe.2006.03.004.
18. Trejo FM, Pérez PF, De Antoni GL. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Antonie Van Leeuwenhoek 2010; 98:19-29; PMID:20232250; http://dx.doi.org/10.1007/s10482-010-9424-6.
19. Chen CY, Nace GW, Irwin PL. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J Microbiol Methods 2003; 55:475-9; PMID:14529971; http://dx.doi.org/10.1016/S0167-7012(03)00194-5.
20. Pawlowski SW, Calabrese G, Kolling GL, Platts-Mills J, Freire R, AlcantaraWarren C, et al. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J Infect Dis 2010; 202:1708-12; PMID:20977342; http://dx.doi.org/10.1086/657086.
21. Houser BA, Hattel AL, Jayarao BM. Real-time multiplex polymerase chain reaction assay for rapid detection of Clostridium difficile toxin-encoding strains. Foodborne Pathog Dis 2010; 7:719-26; PMID:20113206; http://dx.doi.org/10.1089/fpd.2009.0483.
22. Metcalf D, Sharif S, Weese JS. Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe 2010; 16:439-43; PMID:20599622; http://dx.doi.org/10.1016/j.anaerobe.2010.06.007.
23. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367-75; PMID:19307217; http://dx.doi.org/10.1128/IAI.01520-08.